Your browser doesn't support javascript.
loading
Production and Purification of Cysteine-Rich Leptospiral Virulence-Modifying Proteins with or Without mCherry Fusion.
Chaurasia, Reetika; Liang, Cathleen; How, Kenneth; Vieira, Dielson S; Vinetz, Joseph M.
Affiliation
  • Chaurasia R; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. reetika.chaurasia@yale.edu.
  • Liang C; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • How K; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Vieira DS; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Vinetz JM; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. joseph.vinetz@yale.edu.
Protein J ; 42(6): 792-801, 2023 Dec.
Article de En | MEDLINE | ID: mdl-37653175
ABSTRACT
Recombinant fluorescent fusion proteins are fundamental to advancing many aspects of protein science. Such proteins are typically used to enable the visualization of functional proteins in experimental systems, particularly cell biology. An important problem in biotechnology is the production of functional, soluble proteins. Here we report the use of mCherry-fusions of soluble, cysteine-rich, Leptospira-secreted exotoxins in the PF07598 gene family, the so-called virulence modifying (VM) proteins. The mCherry fusion proteins facilitated the visual detection of pink colonies of the VM proteins (LA3490 and LA1402) and following them through lysis and sequential chromatography steps. CD-spectroscopy analysis confirmed the stability and robustness of the mCherry-fusion protein, with a structure comparable to AlphaFold structural predictions. LA0591, a unique member of the PF07598 gene family that lacks N-terminal ricin B-like domains, was produced without mCherry tag that strengthens the recombinant protein production protocol without fusion protein as well. The current study provides the approaches for the synthesis of 50-125 kDa soluble, cysteine-rich, high-quality fast protein liquid chromatography (FPLC)-purified protein, with and without a mCherry tag. The use of mCherry-fusion proteins enables a streamlined, efficient process of protein production and qualitative and quantitative downstream analytical and functional studies. Approaches for troubleshooting and optimization were evaluated to overcome difficulties in recombinant protein expression and purification, demonstrating biotechnology utility in accelerating recombinant protein production.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Qualitative_research Langue: En Journal: Protein J Sujet du journal: BIOQUIMICA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Qualitative_research Langue: En Journal: Protein J Sujet du journal: BIOQUIMICA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...